Javascript must be enabled to continue!
High-mobility group box 1 (HMGB1) mediates DNA methylation preventing genomic instability
View through CrossRef
Global DNA hypomethylation promotes genomic instability through the accumulation of DNA damage and resulted in an increasing rate of mutation. To stabilize the genome, cells possess an epigenetic mechanism to reduce DNA tension that causes DNA damages, named Replication-Independent Endogenous DNA Double-Strand Breaks (RIND-EDSBs). Due to their biological roles, this type of physiologic EDSBs act as youth-associated genomic-stabilizing DNA gaps (Youth-DNA-GAPs). They are localized within methylated genome and maintained by non-histone HMGB1 and SIRT1 proteins. Reduction of RIND-EDSBs was found in hypomethylated genome, including cancer and aging. Therefore, this study aimed to explore the role of HMGB1-mediated DNA methylation in genomic instability prevention. First, using IRS-EDSB LMPCR and DI-PLA methods, we demonstrated that HMGB1, specifically Box-A domain produces Youth-DNA-GAPs. Second, the results from PLA assay revealed that HMGB1 forms complex with Youth-DNA-GAPs and SIRT1, and SIRT1 protected Youth-DNA-GAPs from γH2AX. Third, we conducted two novel PCR, DNA immunoprecipitate 8-OHdG followed by IRS-EDSB LMPCR and IRS-SSB PCR combined with EDSB-SSB PCR to study genome distribution pattern of Youth-DNA-GAPs, and found that Youth-DNA-GAPs are located far from DNA damages and can stabilize genome in long distance. Finally, to study the mechanism of HMGB1-mediated DNA methylation, Alu siRNA and AGO4 transfection were performed. We showed that DNA methylation preventing genomic instability is HMGB1 dependent. Therefore, HMGB1 mediates DNA methylation by producing and maintaining methylated RIND-EDSB or Youth-DNA-GAPs in methylated genome to prevent genomic instability.
Title: High-mobility group box 1 (HMGB1) mediates DNA methylation preventing genomic instability
Description:
Global DNA hypomethylation promotes genomic instability through the accumulation of DNA damage and resulted in an increasing rate of mutation.
To stabilize the genome, cells possess an epigenetic mechanism to reduce DNA tension that causes DNA damages, named Replication-Independent Endogenous DNA Double-Strand Breaks (RIND-EDSBs).
Due to their biological roles, this type of physiologic EDSBs act as youth-associated genomic-stabilizing DNA gaps (Youth-DNA-GAPs).
They are localized within methylated genome and maintained by non-histone HMGB1 and SIRT1 proteins.
Reduction of RIND-EDSBs was found in hypomethylated genome, including cancer and aging.
Therefore, this study aimed to explore the role of HMGB1-mediated DNA methylation in genomic instability prevention.
First, using IRS-EDSB LMPCR and DI-PLA methods, we demonstrated that HMGB1, specifically Box-A domain produces Youth-DNA-GAPs.
Second, the results from PLA assay revealed that HMGB1 forms complex with Youth-DNA-GAPs and SIRT1, and SIRT1 protected Youth-DNA-GAPs from γH2AX.
Third, we conducted two novel PCR, DNA immunoprecipitate 8-OHdG followed by IRS-EDSB LMPCR and IRS-SSB PCR combined with EDSB-SSB PCR to study genome distribution pattern of Youth-DNA-GAPs, and found that Youth-DNA-GAPs are located far from DNA damages and can stabilize genome in long distance.
Finally, to study the mechanism of HMGB1-mediated DNA methylation, Alu siRNA and AGO4 transfection were performed.
We showed that DNA methylation preventing genomic instability is HMGB1 dependent.
Therefore, HMGB1 mediates DNA methylation by producing and maintaining methylated RIND-EDSB or Youth-DNA-GAPs in methylated genome to prevent genomic instability.
Related Results
ROLE OF HMGB1 IN DOXORUBICIN-INDUCED MYOCARDIAL APOPTOSIS AND ITS REGULATION PATHWAY
ROLE OF HMGB1 IN DOXORUBICIN-INDUCED MYOCARDIAL APOPTOSIS AND ITS REGULATION PATHWAY
Objectives
Doxorubicin (DOX) is a widely used anti-tumour agent. The clinical application of the medication is limited by its side effect which can elicit myocard...
Genome wide hypomethylation and youth-associated DNA gap reduction promoting DNA damage and senescence-associated pathogenesis
Genome wide hypomethylation and youth-associated DNA gap reduction promoting DNA damage and senescence-associated pathogenesis
Abstract
Background: Age-associated epigenetic alteration is the underlying cause of DNA damage in aging cells. Two types of youth-associated DNA-protection epigenetic mark...
Genome wide hypomethylation and youth-associated DNA gap reduction promoting DNA damage and senescence-associated pathogenesis
Genome wide hypomethylation and youth-associated DNA gap reduction promoting DNA damage and senescence-associated pathogenesis
Introduction: The United States currently faces two opioid crises, an evolved crisis currently manifesting as widespread abuse of illicit opioids, and a crisis in pain management l...
HMGB1 mediates lipopolysaccharide-induced macrophage autophagy and pyroptosis
HMGB1 mediates lipopolysaccharide-induced macrophage autophagy and pyroptosis
Abstract
Autophagy and pyroptosis of macrophages play important protective or detrimental roles in sepsis. However, the underlying mechanisms remain unclear. High mobility ...
Abstract 2600: HMGB1, a potential new target for mesothelioma therapy
Abstract 2600: HMGB1, a potential new target for mesothelioma therapy
Abstract
Malignant mesothelioma (MM) is a very aggressive cancer that causes 2000-3000 deaths annually in the U.S. and is resistant to current therapies. Diagnosis f...
Role of HMGB1 in Cisplatin-Persistent Lung Adenocarcinoma Cell Lines
Role of HMGB1 in Cisplatin-Persistent Lung Adenocarcinoma Cell Lines
Significant advances have been made recently in the development of targeted therapy for lung adenocarcinoma. However, platinum-based chemotherapy remains as the cornerstone in the ...
Abstract 2094: Correaltions between genome-wide DNA methylation profiles and genomic driver aberrations during multistage lung adenocaricinogenesis
Abstract 2094: Correaltions between genome-wide DNA methylation profiles and genomic driver aberrations during multistage lung adenocaricinogenesis
Abstract
The aim of this study was to clarify correlations between epigenomic and genomic alterations during multistage lung adenocarcinogenesis. Single-CpG resoluti...
Is anti-HMGB1 Antibody a Potential Characteristic Autoantibody for Sjögren's Syndrome?
Is anti-HMGB1 Antibody a Potential Characteristic Autoantibody for Sjögren's Syndrome?
Abstract
BACKGROUND: Sjögren's syndrome (SS) is a common chronic inflammatory autoimmune disease, affects about 0.33% to 0.77% population in China. The positive for antinuc...

